These results were also reported in a study conducted by Sarin et al. in inflammatory diseases (IBD and psoriasis), in which they concluded that IL-23-R381Q variant may confer protection against autoimmunity and excessive inflammation [58]. The gene discussed is IL23A; the disease is inflammatory bowel disease.